Platinum Investment (Asset) Management Ltd
PTM Details
· Average FuM and Fee Revenues slightly down: Platinum Asset Management Limited (ASX: PTM) stock fell 3.17% on November 18, 2016 with some market volatility. PTM’s PAI, which is a new listed investment company debuted in September and New Irish UCITS fund range, Platinum World Portfolios, started in November and has FuM of US$25m over three funds (International, Asia, Japan). Moreover, the average FuM and Fee Revenues for PTM were down 1% for FY 16, and a strong first half being offset by subsequent China volatility and Brexit. PTM reported a 6% fall in the profit after tax to $199.9 million in FY 16 due to lower FX gains, higher staff costs and increased business development spend. However, the margin remained attractive at 82%.
· Recommendation: PTM stock has fallen 13.5% in the last six months as on November 17, 2016 and has a decent dividend yield with a reasonable P/E. We give a “Buy” recommendation on the stock at the current price of – $ 5.20
FY 16 Financial Performance (Source: Company Reports)
Saracen Mineral Holdings Ltd
SAR Details
· Expanding financing facility: Saracen Mineral Holdings Ltd (ASX: SAR) stock fell 5.2% on November 18, 2016 due to falling gold prices. On the other side, SAR has appointed Morgan Ball as Chief Financial Officer, effective from December 05, 2016. Moreover, SAR has entered into A$ 150 million long-term senior corporate financing facility with a syndicate of three major international banks, BNP Paribas, Citibank N.A. and Westpac Banking Corporation. But we believe the pressure in the stock would continue in the coming months which already fell over 21.85% in the last six months as on November 17, 2016.
· Recommendation: Trading at a high P/E, we give an “Expensive” recommendation on the stock at the current price of – $ 1.00
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in: BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.